179 related articles for article (PubMed ID: 38194609)
21. Short-term and long-term effects of tibolone in postmenopausal women.
Formoso G; Perrone E; Maltoni S; Balduzzi S; Wilkinson J; Basevi V; Marata AM; Magrini N; D'Amico R; Bassi C; Maestri E
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD008536. PubMed ID: 27733017
[TBL] [Abstract][Full Text] [Related]
22. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
Nelson HD; Vesco KK; Haney E; Fu R; Nedrow A; Miller J; Nicolaidis C; Walker M; Humphrey L
JAMA; 2006 May; 295(17):2057-71. PubMed ID: 16670414
[TBL] [Abstract][Full Text] [Related]
23. Phytoestrogens for vasomotor menopausal symptoms.
Lethaby AE; Brown J; Marjoribanks J; Kronenberg F; Roberts H; Eden J
Cochrane Database Syst Rev; 2007 Oct; (4):CD001395. PubMed ID: 17943751
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis.
Shan D; Zou L; Liu X; Shen Y; Cai Y; Zhang J
Am J Obstet Gynecol; 2020 Jun; 222(6):564-579.e12. PubMed ID: 31870736
[TBL] [Abstract][Full Text] [Related]
25. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
Toulis KA; Tzellos T; Kouvelas D; Goulis DG
Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
[TBL] [Abstract][Full Text] [Related]
26. Beyond frequency: who is most bothered by vasomotor symptoms?
Thurston RC; Bromberger JT; Joffe H; Avis NE; Hess R; Crandall CJ; Chang Y; Green R; Matthews KA
Menopause; 2008; 15(5):841-7. PubMed ID: 18521049
[TBL] [Abstract][Full Text] [Related]
27. Exercise for vasomotor menopausal symptoms.
Daley A; MacArthur C; Mutrie N; Stokes-Lampard H
Cochrane Database Syst Rev; 2007 Oct; (4):CD006108. PubMed ID: 17943886
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of a Proprietary Trigonella foenum-graecum L. De-Husked Seed Extract in Reducing Menopausal Symptoms in Otherwise Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Study.
Steels E; Steele ML; Harold M; Coulson S
Phytother Res; 2017 Sep; 31(9):1316-1322. PubMed ID: 28707431
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of desvenlafaxine treatment for hot flashes associated with menopause: a meta-analysis of randomized controlled trials.
Sun Z; Hao Y; Zhang M
Gynecol Obstet Invest; 2013; 75(4):255-62. PubMed ID: 23548358
[TBL] [Abstract][Full Text] [Related]
30. A prospective, multicenter, randomized, double-blind placebo-controlled trial on purified and specific Cytoplasmic pollen extract for hot flashes in breast cancer survivors.
Bounous VE; Cipullo I; D'Alonzo M; Martella S; Franchi D; Villa P; Biglia N; Ferrero A
Gynecol Endocrinol; 2024 Dec; 40(1):2334796. PubMed ID: 38760920
[TBL] [Abstract][Full Text] [Related]
31. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
Tice JA; Ettinger B; Ensrud K; Wallace R; Blackwell T; Cummings SR
JAMA; 2003 Jul; 290(2):207-14. PubMed ID: 12851275
[TBL] [Abstract][Full Text] [Related]
32. Is desvenlafaxine effective and safe in the treatment of menopausal vasomotor symptoms? A meta-analysis and meta-regression of randomized double-blind controlled studies.
Berhan Y; Berhan A
Ethiop J Health Sci; 2014 Jul; 24(3):209-18. PubMed ID: 25183927
[TBL] [Abstract][Full Text] [Related]
33. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.
Maclennan AH; Broadbent JL; Lester S; Moore V
Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD002978. PubMed ID: 15495039
[TBL] [Abstract][Full Text] [Related]
34. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
Utian WH
Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials.
Riemma G; Schiattarella A; La Verde M; Zarobbi G; Garzon S; Cucinella G; Calagna G; Labriola D; De Franciscis P
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480427
[No Abstract] [Full Text] [Related]
36. The pollen extract Femal--a nonestrogenic alternative to hormone therapy in women with menopausal symptoms.
Hellström AC; Muntzing J
Menopause; 2012 Jul; 19(7):825-9. PubMed ID: 22334059
[TBL] [Abstract][Full Text] [Related]
37. Vasomotor symptoms and management of women undergoing treatment for breast cancer: literature review with focus on the therapeutic potential of cytoplasmic pollen extract.
Lello S; Paris I; Cagnacci A; Sartori D; Caruso S; Iop A
Gynecol Endocrinol; 2023 Dec; 39(1):2162035. PubMed ID: 36591791
[TBL] [Abstract][Full Text] [Related]
38. Effects of exogenous melatonin on sleep quality and menopausal symptoms in menopausal women: a systematic review and meta-analysis of randomized controlled trials.
Yi M; Wang S; Wu T; Zhang X; Jiang L; Fang X
Menopause; 2021 Mar; 28(6):717-725. PubMed ID: 33784263
[TBL] [Abstract][Full Text] [Related]
39. Add-back therapy with GnRH analogues for uterine fibroids.
Moroni RM; Martins WP; Ferriani RA; Vieira CS; Nastri CO; Candido Dos Reis FJ; Brito LG
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010854. PubMed ID: 25793972
[TBL] [Abstract][Full Text] [Related]
40. SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials.
Shams T; Firwana B; Habib F; Alshahrani A; Alnouh B; Murad MH; Ferwana M
J Gen Intern Med; 2014 Jan; 29(1):204-13. PubMed ID: 23888328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
